Bodycote holders learned on 30 October 2026 that the financing behind Veritas Capital's recommended 940p-a-share Takeover had been rearranged, nine days after shareholders approved the deal.

What happened

The heat treatment and specialist metallurgy group, ticker LSE:BOY, is listed on our coverage as a constituent of the FTSE All-Share index and sits in the industrial engineering sector. It remains in a Takeover Code offer period, and so is expected to leave the index if the Acquisition completes.

Details of the financing update come from an AI-generated summary on, because the page retrieved did not carry the full announcement. It warns of possible inaccuracies, so readers should check the original release. (LSE:BOY)

According to that summary, the Equity commitment from The Veritas Capital Fund IX was amended and restated, falling from about $1.51 billion to about $1.29 billion. The change was attributed to a foreign exchange hedge agreement. Debt documents were also amended, adding Barclays and HSBC as interim lenders alongside the original group.

The same summary says Bodycote shareholders approved the scheme on 21 October. The bidding vehicle is Vulcan Alpha Bidco Limited.

The terms

Hargreaves Lansdown's report of the 1 September announcement gave the offer as 940p per share. That comprises 932.8p in cash plus the 2026 Interim Dividend of 7.2p, and values the company at £1.65 billion.

The report put the premium at 44% over the closing price on 7 July, the last Business day before Veritas's initial proposal. Chair Daniel Dayan said the board "remains highly confident in Bodycote's prospects" while recommending the offer.

There were rival approaches. CVC had made an approach and faced a 2 September deadline to bid or walk away, and a later headline reports that it dropped its pursuit. An earlier proposal from Apollo, valued at $2.04 billion in another headline, had also been confirmed. Those parties do not appear in the 30 October summary.

Why it matters for investors

Our analysis is that the reduction in the equity figure should be read with its stated reason. On the summary's account, it reflects a currency hedge, and it does not mention any change to the price offered to shareholders. A dollar-based fund buying a sterling-priced company has a clear interest in fixing its exchange rate.

For remaining shareholders, the matter of interest is certainty of funds, and the addition of two further interim lenders does not, on its face, suggest a problem. Investors should nevertheless read the announcement in full to confirm the exact mechanics.

Once shareholders have approved a scheme, the remaining questions are mostly about timing. Those are the regulatory conditions and the court sanction, neither of which appeared in the material retrieved.

How the shares have performed

A current price could not be retrieved. The last price available is from the 1 September report, which showed the shares up 4.4% at 953.05p at 09:47 that morning, slightly above the offer while CVC was still considering its position.

Since then the competitive tension appears to have eased, so that price should not be taken as a guide to today's level.

What to watch next

Holdings notices have continued, with filings on 28 and 29 October and 2 November, alongside Form 8 disclosures. Those filings show Shareholder positions are still moving while the deal is pending.

The next formal steps are regulatory clearances and a court hearing to sanction the scheme, followed by cancellation of the listing. A date for each should be published as the timetable firms up.